Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. - Gajjar,A.; Hernan,R.; Kocak,M.; Fuller,C.; Lee,Y.; McKinnon,P.J.; Wallace,D.; Lau,C.; Chintagumpala,M.; Ashley,D.M.; Kellie,S.J.; Kun,L.; et al. (J Clin Oncol, 2004)